Skip to content
π Amphotericin B (c) Liposomal Amphotericin B β Injection 50 mg
π Description:
- Liposomal Amphotericin B is a lipid-based formulation where Amphotericin B is encapsulated in liposomes (tiny vesicles).
- It is presented as a sterile, lyophilized powder, to be reconstituted and given via intravenous infusion.
- Each vial contains 50 mg of Amphotericin B, embedded in liposomes composed of phospholipids and cholesterol.
- Liposomal form is specifically engineered to reduce toxicity and improve targeting of infected tissues.
- It is a high-cost, high-efficacy antifungal for serious systemic fungal infections.
πΏ Nature:
- It is a polyene antifungal agent, designed as a liposome-encapsulated formulation.
- The liposomes enhance selective delivery to fungal-infected cells while sparing human cells.
- Administered via slow intravenous infusion, not intended for IM or IV bolus.
- Known for its low immunogenicity and improved patient tolerability.
- Due to its liposomal nature, it distributes well into RES tissues and crosses barriers like the blood-brain barrier more effectively.
β
Advantages:
- Significantly reduced nephrotoxicity compared to conventional Amphotericin B.
- Better tolerance during infusion β fewer chills, rigors, and fever.
- Allows higher dosing with fewer adverse effects, improving efficacy.
- Improved drug distribution to infected tissues, especially in deep mycoses.
- Preferred antifungal for immunocompromised patients, including neonates and transplant patients.
π©Ί Uses:
- Treatment of life-threatening systemic fungal infections like aspergillosis, cryptococcosis, and mucormycosis.
- Visceral leishmaniasis, especially in HIV patients or where sodium stibogluconate fails.
- Empiric therapy for febrile neutropenic patients unresponsive to broad-spectrum antibiotics.
- Prophylaxis and treatment in patients undergoing hematopoietic stem cell transplant or chemotherapy.
- Effective in fungal CNS infections, due to enhanced CNS penetration.
βοΈ Storage:
- Store unopened vials at 2β8Β°C in a refrigerator, protected from light.
- Do not freeze either the powder or the reconstituted solution.
- After reconstitution, the solution should be used within 24 hours (if refrigerated).
- Reconstitute using sterile water for injection only, following the manufacturerβs instructions.
- Administer via IV infusion over 2+ hours to minimize infusion-related adverse effects.
Call Now Button